Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
ConditionEctopic Pregnancy
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorKafrelsheikh University
About this trial
The aim of work is to study the effectiveness of letrozole in treatment of early undisturbed ectopic pregnancy in comparison with Methotrexate.
Eligibility criteria
Qualifiers
Confirmed ectopic pregnancy on trans vaginal ultrasound
Age between 20 and 35 years
A β-hCG levels < 3000 Iu/ L
The average diameter of the adnexal mass ≤3.5 cm
Disqualifiers
Presence of fetal heart pulsation
Heterotopic pregnancy
Presence of significant abdominal pain
history of allergic reactions to MTX or letrozole
Trial design
Treatments tested in this trial
- Methotrexate (drug)
- Letrozole 2.5Mg Tab
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov